Far fewer babies had severe cases of the respiratory illness RSV, in a winter in which a new monoclonal and vaccine became ...

(Reuters) -Infant hospitalizations due to respiratory syncytial virus (RSV) infections in the United States dropped as much ...

A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...

Here's what RSV is, why it especially impacts the youngest and oldest members of society and how it is usually treated.

A study published earlier this week in Nature Communications using claims data from the US Veterans Affairs (VA) Healthcare ...

In a study published in the Journal of the American Medical Association, researchers from Moderna reported that the new combo ...

The infant mortality national rate dropped to about 5.5 infant deaths per 1,000 live births in 2024, according to provisional ...

RiverStone Health encourages everyone to receive the updated COVID-19 vaccine as recommended by the Centers for Disease ...

"It used to take eight to 10 years to develop a vaccine. But it only took 11 months from the SARS-CoV-2 being gene-sequenced ...

by Timothy McQuiston, Vermont Business Magazine The Vermont Department of Health reported last week that the number of ...

A new vaccine that combines flu and COVID-19 protection in one shot shows promising results, but the U.S. Food and Drug ...